Search results
Crucial to equip soldiers with modern weapons, tech: Army chief General Dwivedi
Hindustan Times· 1 hour agoIn his maiden address as army chief, he also touched upon indigenisation of military hardware,...
As Pakistan launches its latest counter-terror operation, Islamabad cannot have double standards...
Firstpost· 2 hours agoAmid a surge in terror incidents, which Pakistan blames on the banned Tehreek-i-Taliban Pakistan...
'There can be safety concerns.' Sympathy, caution from Cape Codders after Riviello death
Cape Cod Times· 3 hours agoIt remains unclear whether Riviello's release had anything to do with hospital protocols, a lack of...
Rohit Sharma: Real, raw and a true romantic
Firstpost· 3 hours agoLudwig Van Beethovan wrote a love letter to his ‘immortal beloved’. Only by calm consideration of our existence can we achieve our purpose to live...
Add a cool summer crochet shirt to your handmade wardobe
Prima· 3 hours agoNext row (RS): ch3, sl st in 2chsp, *ch4, sl st in 2chsp to last chsp, ch3, sl st in last st, turn....
Ajit Ranade on how to deal with China: Dialogue, deterrence and trade
Livemint· 5 hours agoIndia’s capacity now fulfils 97% of the domestic demand for handsets, plus earned $15 billion in...
How one of the world's strongest car unions is dealing with EV job losses - The Economic Times
The Economic Times· 5 hours agoThe threat to jobs caused by the electric vehicle transition isn’t just a hot-button issue in the US, where a presidential election campaign ...
GRSE shares jump 8% after signing construction contract with Bangladesh government - The Economic...
The Economic Times· 5 hours agoShares of Garden Reach Shipbuilders & Engineers (GRSE) rose 8% to its new all-time high of Rs 2,268...
Should you prefer RR Kabel over Polycab? Amnish Aggarwal explains why
The Economic Times· 6 hours agoIf the current valuation is compared to this stock price, Aggarwal prefers RR Kabel over Polycab...
10 clinical trials to watch in the second half of 2024
BioPharma Dive· 7 hours agoStudy results are expected for a pair of closely watched obesity drugs, while key tests await for a...